This year’s Advanced Technologies and Treatments for Diabetes (ATTD) conference in Barcelona was packed with major announcements and a clear look at where diabetes technology is heading next. Fully closed loop insulin delivery emerged as the dominant theme, alongside advances in automation, sensing, and AI.

Several companies shared progress toward reducing or eliminating the requirement for meal announcements and manual inputs required by today’s hybrid closed loop systems. MiniMed presented feasibility data for its new Vivera algorithm, showing adults achieving more than 70% time in range (TIR) without announcing meals. CamAPS introduced Liberty, a secondary algorithm feature designed to remove mealtime boluses, while Omnipod focused on type 2 diabetes with its EVOLVE algorithm, demonstrating improved TIR without requiring bolus decisions.

The conference also highlighted Abbott’s work on continuous dual glucose-ketone monitoring, Dexcom’s Smart Basal feature for optimizing long-acting insulin dosing in type 2 diabetes, and the growing role of AI, from food photo recognition in apps like Libre Assist to people analyzing their own CGM data using large language models.

Our latest podcast episode breaks down everything with endocrinologist and diabetes tech expert Dr. David Ahn. Listen above or watch the video below.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.